TRADE
Peptide hormone trade by country
Customs statistics have no code for a single peptide. The nearest codes count all polypeptide hormones as bulk substances (2937.19) and the medicines made from them (3004.39), so semaglutide, oxytocin and dozens of others share one figure. Read every number as that whole group.
Answer
UN Comtrade, 2025, largest exporters of bulk polypeptide hormones among the 8 countries reporting: United States $18.5 bn, Switzerland $1.3 bn, China $894 m. Eurostat Comext, 2025, largest exporters of bulk polypeptide hormones among the 27 countries reporting: Ireland €53.9 bn, Denmark €3.2 bn, Germany €222 m.
A proxy for peptide trade, not a measure of any one peptide.
UN COMTRADE · 2025
HS 2937.19: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
Exports, USD million
Imports, USD million
Statistics office UN Comtrade, code 2937.19, read 2026-10-03. Countries that did not report are left out, not shown as zero. Source query.
UN COMTRADE · 2025
HS 3004.39: medicines in measured doses containing such hormones, other than insulin and corticosteroids
Exports, USD million
Imports, USD million
Statistics office UN Comtrade, code 3004.39, read 2026-10-03. Countries that did not report are left out, not shown as zero. Source query.
EUROSTAT COMEXT · 2025
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
Exports, EUR million
12 more countries reported smaller exports; all are under By country.
Imports, EUR million
15 more countries reported smaller imports; all are under By country.
Statistics office Eurostat Comext, code 29371900, read 2026-10-03. Countries that did not report are left out, not shown as zero. Source query.
EUROSTAT COMEXT · 2025
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
Exports, EUR million
14 more countries reported smaller exports; all are under By country.
Imports, EUR million
15 more countries reported smaller imports; all are under By country.
Statistics office Eurostat Comext, code 30043900, read 2026-10-03. Countries that did not report are left out, not shown as zero. Source query.
BY COUNTRY
Every year reported, with the largest partners
Canada UN Comtrade, USD
HS 2937.19: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | $2 m | $11 m |
| 2023 | $2 m | $17 m |
| 2024 | $6 m | $35 m |
| 2025 | $40 m | $78 m |
Largest destinations, 2025: United States $32 m, Denmark $8 m, Brazil $24,443, Germany $17,917, South Korea $9,450, Thailand $8,052, Poland $7,006, Mexico $4,212, Austria $3,825, Portugal $2,699.
Largest origins, 2025: United States $62 m, China $10 m, India $2 m, Belgium $1 m, Sweden $1 m, Spain $255,126, Netherlands $205,227, Austria $156,462, Israel $99,862, Germany $94,058.
HS 3004.39: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | $701 m | $526 m |
| 2023 | $836 m | $602 m |
| 2024 | $791 m | $621 m |
| 2025 | $554 m | $625 m |
Largest destinations, 2025: United States $207 m, Japan $135 m, Italy $118 m, Belgium $50 m, China $9 m, South Africa $6 m, Hungary $4 m, Spain $4 m, Poland $3 m, Netherlands $2 m.
Largest origins, 2025: United States $126 m, Switzerland $65 m, Denmark $64 m, Italy $57 m, Germany $51 m, United Kingdom $51 m, Ireland $48 m, Spain $43 m, Austria $31 m, Belgium $26 m.
China UN Comtrade, USD
HS 2937.19: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | $227 m | $387 m |
| 2023 | $326 m | $1.6 bn |
| 2024 | $493 m | $2.2 bn |
| 2025 | $894 m | $3.3 bn |
Largest destinations, 2025: United States $391 m, Italy $106 m, Russia $72 m, India $69 m, Switzerland $47 m, Paraguay $38 m, Germany $30 m, Brazil $27 m, Japan $22 m, South Korea $14 m.
Largest origins, 2025: Denmark $3.1 bn, Germany $157 m, United States $19 m, Switzerland $3 m, France $3 m, India $2 m, Spain $278,851, Netherlands $98,870, Sweden $85,041, Ireland $20,579.
HS 3004.39: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | $575 m | $2.6 bn |
| 2023 | $1.0 bn | $3.0 bn |
| 2024 | $1.4 bn | $3.6 bn |
| 2025 | $3.0 bn | $3.6 bn |
Largest destinations, 2025: France $1.2 bn, Denmark $1.2 bn, Italy $421 m, Australia $60 m, United States $56 m, Algeria $14 m, Brazil $11 m, South Korea $8 m, Egypt $7 m, India $6 m.
Largest origins, 2025: Italy $1.0 bn, Denmark $972 m, Germany $403 m, United Kingdom $382 m, Netherlands $226 m, France $207 m, United States $134 m, Japan $83 m, Austria $45 m, Switzerland $37 m.
India UN Comtrade, USD
HS 2937.19: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | $26 m | $47 m |
| 2023 | $31 m | $34 m |
| 2024 | $34 m | $39 m |
| 2025 | $43 m | $62 m |
Largest destinations, 2025: United States $13 m, United Kingdom $3 m, South Korea $3 m, Spain $2 m, Germany $2 m, Canada $2 m, Egypt $2 m, France $2 m, Paraguay $2 m, Türkiye $2 m.
Largest origins, 2025: China $49 m, Switzerland $4 m, France $2 m, Germany $2 m, Spain $2 m, United States $991,243, Greece $761,552, India $322,116, Denmark $263,105, Sweden $187,580.
HS 3004.39: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | $145 m | $50 m |
| 2023 | $146 m | $66 m |
| 2024 | $213 m | $53 m |
| 2025 | $261 m | $185 m |
Largest destinations, 2025: United States $104 m, United Kingdom $15 m, Nigeria $8 m, Jordan $7 m, Canada $7 m, Russia $6 m, Philippines $6 m, France $5 m, United Arab Emirates $5 m, Kenya $5 m.
Largest origins, 2025: Italy $101 m, United States $30 m, Switzerland $15 m, Germany $14 m, Belgium $6 m, Netherlands $4 m, South Korea $3 m, Ireland $3 m, Austria $2 m, United Kingdom $2 m.
Japan UN Comtrade, USD
HS 2937.19: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | $966,827 | $94 m |
| 2023 | $678,288 | $86 m |
| 2024 | $687,154 | $65 m |
| 2025 | $820,108 | $62 m |
Largest destinations, 2025: Germany $382,335, China $152,860, Sweden $69,026, South Korea $64,961, United States $56,989, Singapore $27,562, India $21,711, France $20,195, Netherlands $12,636, Hong Kong SAR China $7,985.
Largest origins, 2025: Germany $27 m, China $17 m, Sweden $7 m, Netherlands $6 m, Switzerland $2 m, Argentina $2 m, United States $637,914, Spain $323,720, India $72,007, Canada $60,586.
HS 3004.39: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | $298 m | $1.2 bn |
| 2023 | $217 m | $1.5 bn |
| 2024 | $216 m | $1.8 bn |
| 2025 | $230 m | $1.8 bn |
Largest destinations, 2025: United States $111 m, Italy $31 m, Netherlands $23 m, China $20 m, South Korea $16 m, Thailand $7 m, Finland $4 m, Hong Kong SAR China $2 m, Indonesia $1 m, Philippines $306,306.
Largest origins, 2025: Denmark $554 m, Germany $377 m, United States $326 m, Canada $131 m, Italy $73 m, Switzerland $68 m, United Kingdom $65 m, France $49 m, Spain $47 m, Austria $32 m.
South Korea UN Comtrade, USD
HS 2937.19: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | $186,742 | $28 m |
| 2023 | $1 m | $27 m |
| 2024 | $434,801 | $21 m |
| 2025 | $1 m | $26 m |
Largest destinations, 2025: United States $966,653, India $320,520, Japan $71,739, Italy $26,600, Croatia $16,744, Thailand $12,747, Malaysia $10,830, Colombia $10,500, China $9,539, Australia $6,250.
Largest origins, 2025: China $16 m, India $4 m, Sweden $2 m, United States $2 m, Switzerland $1 m, Spain $682,523, Japan $636,696, Israel $163,729, Canada $91,920, Italy $71,689.
HS 3004.39: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | $76 m | $377 m |
| 2023 | $97 m | $408 m |
| 2024 | $112 m | $501 m |
| 2025 | $93 m | $1.2 bn |
Largest destinations, 2025: Brazil $16 m, Vietnam $16 m, Thailand $14 m, Mexico $6 m, China $6 m, Pakistan $5 m, India $3 m, United Arab Emirates $3 m, Iraq $3 m, Jordan $3 m.
Largest origins, 2025: Denmark $561 m, United States $292 m, Germany $78 m, Switzerland $63 m, France $34 m, Belgium $32 m, Japan $28 m, United Kingdom $24 m, Sweden $24 m, Italy $24 m.
Switzerland UN Comtrade, USD
HS 2937.19: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | $2.7 bn | $78 m |
| 2023 | $3.4 bn | $86 m |
| 2024 | $969 m | $90 m |
| 2025 | $1.3 bn | $105 m |
Largest destinations, 2025: Austria $817 m, Italy $224 m, United States $93 m, France $50 m, United Kingdom $46 m, Denmark $41 m, Germany $14 m, Croatia $9 m, India $8 m, China $6 m.
Largest origins, 2025: Italy $42 m, Spain $20 m, Ireland $13 m, United States $10 m, China $8 m, Sweden $5 m, France $5 m, Netherlands $1 m, Germany $739,853, Argentina $307,680.
HS 3004.39: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | $3.4 bn | $3.7 bn |
| 2023 | $3.1 bn | $3.2 bn |
| 2024 | $3.2 bn | $3.2 bn |
| 2025 | $3.4 bn | $2.8 bn |
Largest destinations, 2025: United States $990 m, Netherlands $784 m, Germany $266 m, Italy $157 m, China $135 m, France $88 m, Japan $75 m, South Korea $69 m, Spain $49 m, Saudi Arabia $49 m.
Largest origins, 2025: Austria $1.8 bn, Germany $235 m, Italy $230 m, Denmark $198 m, France $133 m, United States $53 m, Spain $34 m, United Kingdom $31 m, Ireland $22 m, Japan $11 m.
United Kingdom UN Comtrade, USD
HS 2937.19: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | $1 m | $48 m |
| 2023 | $2 m | $47 m |
| 2024 | $2 m | $46 m |
| 2025 | $2 m | $67 m |
Largest destinations, 2025: United States $1 m, Kuwait $219,460, Germany $215,498, Switzerland $136,496, India $103,813, Netherlands $62,289, France $57,243, Ireland $49,710, Italy $28,351, Argentina $24,989.
Largest origins, 2025: Switzerland $51 m, Sweden $10 m, China $2 m, United States $1 m, Israel $820,829, France $456,723, India $221,300, Netherlands $193,496, Germany $145,548, Spain $109,335.
HS 3004.39: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | $1.0 bn | $1.3 bn |
| 2023 | $1.0 bn | $1.4 bn |
| 2024 | $1.2 bn | $3.1 bn |
| 2025 | $1.3 bn | $6.2 bn |
Largest destinations, 2025: China $433 m, Belgium $147 m, United States $82 m, Brazil $76 m, Germany $66 m, Japan $50 m, Netherlands $43 m, Denmark $34 m, South Korea $33 m, Switzerland $29 m.
Largest origins, 2025: Italy $3.3 bn, China $1.1 bn, Denmark $423 m, Ireland $331 m, France $274 m, Germany $221 m, United States $163 m, Spain $53 m, Belgium $48 m, Brazil $40 m.
United States UN Comtrade, USD
HS 2937.19: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | $944 m | $5.3 bn |
| 2023 | $5.1 bn | $8.7 bn |
| 2024 | $9.2 bn | $16.4 bn |
| 2025 | $18.5 bn | $57.8 bn |
Largest destinations, 2025: Italy $15.4 bn, Germany $2.0 bn, France $331 m, Austria $253 m, Denmark $221 m, Spain $108 m, Canada $63 m, China $39 m, Brazil $38 m, Ireland $11 m.
Largest origins, 2025: Ireland $56.3 bn, China $1.1 bn, Switzerland $93 m, Argentina $71 m, Sweden $60 m, Denmark $46 m, Canada $32 m, India $25 m, Germany $12 m, Austria $6 m.
HS 3004.39: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | $1.3 bn | $11.1 bn |
| 2023 | $1.7 bn | $10.5 bn |
| 2024 | $3.3 bn | $6.9 bn |
| 2025 | $3.8 bn | $6.1 bn |
Largest destinations, 2025: Brazil $785 m, Japan $528 m, Mexico $321 m, France $293 m, South Korea $287 m, Netherlands $285 m, China $185 m, Canada $163 m, United Arab Emirates $111 m, Spain $90 m.
Largest origins, 2025: Ireland $1.4 bn, Denmark $787 m, Germany $708 m, Switzerland $684 m, Italy $455 m, Netherlands $319 m, Canada $245 m, Austria $213 m, India $207 m, France $179 m.
Austria Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €492 m | €2.6 bn |
| 2023 | €15 m | €3.3 bn |
| 2024 | €336 m | €595 m |
| 2025 | €94 m | €982 m |
Largest destinations, 2025: France €71 m, Hungary €9 m, United States €7 m, Germany €4 m, Switzerland €2 m, Italy €490,817, Spain €315,041, Iran €240,165, Canada €119,872, Finland €54,322.
Largest origins, 2025: Switzerland €737 m, United States €242 m, Germany €1 m, Spain €891,150, India €266,836, China €146,712, Indonesia €89,793, Belgium €17,512, France €11,054, Canada €10,589.
Latest months, exports to the world: 2026-01 €77 m, 2026-02 €81 m, 2026-03 €2 m, 2026-04 €12 m, 2026-05 €2 m, 2026-06 €7 m.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €2.1 bn | €148 m |
| 2023 | €1.6 bn | €141 m |
| 2024 | €1.4 bn | €155 m |
| 2025 | €794 m | €186 m |
Largest destinations, 2025: Switzerland €611 m, United States €32 m, Germany €22 m, Singapore €16 m, Mexico €9 m, Australia €8 m, Poland €6 m, Türkiye €6 m, Saudi Arabia €6 m, Romania €6 m.
Largest origins, 2025: Germany €79 m, Denmark €45 m, France €30 m, Belgium €14 m, Netherlands €4 m, Czechia €3 m, Hungary €3 m, Italy €2 m, Switzerland €1 m, Slovenia €1 m.
Latest months, exports to the world: 2026-01 €73 m, 2026-02 €33 m, 2026-03 €69 m, 2026-04 €80 m, 2026-05 €58 m, 2026-06 €91 m.
Belgium Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €32 m | €434 m |
| 2023 | €62 m | €197 m |
| 2024 | €30 m | €174 m |
| 2025 | €51 m | €262 m |
Largest destinations, 2025: Ireland €39 m, France €3 m, Germany €3 m, United States €3 m, Canada €2 m, Netherlands €1 m, United Arab Emirates €381,369, Poland €89,824, South Africa €33,408, Brazil €25,948.
Largest origins, 2025: Ireland €247 m, China €7 m, Denmark €6 m, United States €995,170, Germany €87,928, Australia €71,322, Latvia €53,910, Netherlands €49,994, France €28,787, India €14,280.
Latest months, exports to the world: 2026-01 €6 m, 2026-02 €6 m, 2026-03 €15 m, 2026-04 €15 m, 2026-05 €68,285, 2026-06 €66,301.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €2.9 bn | €2.3 bn |
| 2023 | €2.3 bn | €1.7 bn |
| 2024 | €2.4 bn | €1.8 bn |
| 2025 | €2.5 bn | €2.3 bn |
Largest destinations, 2025: United States €356 m, France €263 m, China €251 m, Netherlands €199 m, Italy €155 m, Australia €117 m, United Kingdom €102 m, Germany €93 m, Spain €64 m, Taiwan €55 m.
Largest origins, 2025: Italy €774 m, France €733 m, Germany €163 m, Canada €144 m, Denmark €120 m, United Kingdom €88 m, Netherlands €73 m, Spain €55 m, Sweden €44 m, Switzerland €31 m.
Latest months, exports to the world: 2026-01 €159 m, 2026-02 €185 m, 2026-03 €178 m, 2026-04 €205 m, 2026-05 €186 m, 2026-06 €367 m.
Bulgaria Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | not reported | €24,471 |
| 2023 | not reported | €51,635 |
| 2024 | €1,631 | €56,771 |
| 2025 | not reported | €33,760 |
Largest destinations, 2024: Iran €1,631.
Largest origins, 2025: China €25,677, United States €4,267, Germany €2,460, Austria €877, United Kingdom €287, Slovakia €192.
Latest months, exports to the world: none reported.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €30 m | €49 m |
| 2023 | €54 m | €50 m |
| 2024 | €50 m | €62 m |
| 2025 | €62 m | €80 m |
Largest destinations, 2025: Russia €23 m, Germany €11 m, Kazakhstan €5 m, Ukraine €4 m, Lithuania €3 m, Romania €3 m, Latvia €2 m, United Kingdom €2 m, Netherlands €2 m, North Macedonia €1 m.
Largest origins, 2025: Denmark €22 m, Germany €22 m, France €13 m, Switzerland €5 m, Belgium €4 m, Hungary €4 m, Slovenia €3 m, Netherlands €2 m, Croatia €1 m, Italy €1 m.
Latest months, exports to the world: 2026-01 €5 m, 2026-02 €4 m, 2026-03 €8 m, 2026-04 €9 m, 2026-05 €4 m, 2026-06 €11 m.
Croatia Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €2,846 | €11 m |
| 2023 | €18,423 | €10 m |
| 2024 | not reported | €18 m |
| 2025 | €16,798 | €12 m |
Largest destinations, 2025: United States €15,343, United Kingdom €1,455.
Largest origins, 2025: United States €6 m, Switzerland €3 m, Germany €2 m, China €732,199, India €20,031, Sweden €14,541, France €1,315, Norway €1,128, Israel €10, QW €1.
Latest months, exports to the world: 2025-10 €15,343.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €18 m | €34 m |
| 2023 | €25 m | €38 m |
| 2024 | €35 m | €44 m |
| 2025 | €28 m | €56 m |
Largest destinations, 2025: Denmark €16 m, Germany €5 m, Czechia €3 m, United Kingdom €2 m, Lithuania €866,515, Romania €611,578, Ukraine €344,426, Bosnia & Herzegovina €189,195, Slovenia €174,153, Hungary €170,974.
Largest origins, 2025: Germany €27 m, Denmark €9 m, Slovenia €6 m, Switzerland €3 m, Austria €3 m, Poland €2 m, Italy €1 m, France €1 m, Hungary €1 m, Belgium €763,940.
Latest months, exports to the world: 2026-01 €1 m, 2026-02 €1 m, 2026-03 €2 m, 2026-04 €3 m, 2026-05 €2 m, 2026-06 €3 m.
Cyprus Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | not reported | €43,228 |
| 2023 | not reported | €185,480 |
| 2024 | €65,336 | €3,053 |
| 2025 | not reported | €3,562 |
Largest destinations, 2024: Greece €64,464, France €872.
Largest origins, 2025: Israel €3,194, France €268, Germany €100.
Latest months, exports to the world: none reported.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €6 m | €6 m |
| 2023 | €16 m | €6 m |
| 2024 | €24 m | €8 m |
| 2025 | €16 m | €17 m |
Largest destinations, 2025: France €12 m, Portugal €1 m, Netherlands €939,014, Italy €532,634, Spain €457,409, Sweden €383,608, Georgia €359,370, Greece €133,164, North Macedonia €78,884.
Largest origins, 2025: Spain €6 m, Greece €4 m, Italy €3 m, Switzerland €1 m, Austria €824,571, Germany €637,978, Netherlands €524,657, Sweden €493,615, United Arab Emirates €355,993, Belgium €275,932.
Latest months, exports to the world: 2026-01 €6 m, 2026-02 €4 m, 2026-03 €4 m, 2026-04 €2 m, 2026-05 €1 m, 2026-06 €5 m.
Czechia Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €386,974 | €2 m |
| 2023 | €620,849 | €2 m |
| 2024 | €19,203 | €1 m |
| 2025 | €161,324 | €2 m |
Largest destinations, 2025: Russia €114,689, Ukraine €19,978, Uzbekistan €13,457, India €7,493, Switzerland €4,893, Slovakia €721, United States €93.
Largest origins, 2025: France €1 m, Sweden €806,925, United States €151,787, China €142,095, Latvia €48,213, Germany €31,826, Spain €22,474, Canada €10,762, Netherlands €8,959, United Kingdom €7,943.
Latest months, exports to the world: 2026-01 €26,795, 2026-03 €33,057, 2026-04 €27,338, 2026-05 €69,014, 2026-06 €84,189, 2026-07 €23,851.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €220 m | €360 m |
| 2023 | €204 m | €395 m |
| 2024 | €198 m | €432 m |
| 2025 | €256 m | €547 m |
Largest destinations, 2025: Germany €121 m, Slovakia €36 m, Denmark €33 m, Hungary €17 m, United Kingdom €7 m, France €6 m, Poland €5 m, Netherlands €5 m, Austria €3 m, Ireland €3 m.
Largest origins, 2025: Denmark €178 m, Germany €124 m, France €96 m, Italy €30 m, Belgium €29 m, Slovakia €26 m, Spain €9 m, Austria €8 m, Hungary €8 m, Romania €7 m.
Latest months, exports to the world: 2026-02 €23 m, 2026-03 €27 m, 2026-04 €24 m, 2026-05 €26 m, 2026-06 €26 m, 2026-07 €25 m.
Denmark Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €1.5 bn | €70 m |
| 2023 | €1.2 bn | €225 m |
| 2024 | €1.8 bn | €618 m |
| 2025 | €3.2 bn | €541 m |
Largest destinations, 2025: QZ €3.1 bn, QY €113 m.
Largest origins, 2025: United States €258 m, Italy €223 m, Portugal €32 m, Sweden €12 m, Canada €7 m, Switzerland €7 m, Netherlands €824,636, Germany €797,649, Belgium €779,918, China €360,865.
Latest months, exports to the world: 2026-01 €209 m, 2026-02 €63 m, 2026-03 €233 m, 2026-04 €154 m, 2026-05 €68 m, 2026-06 €87 m.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | not reported | €991 m |
| 2023 | not reported | €702 m |
| 2024 | not reported | €1.0 bn |
| 2025 | not reported | €1.3 bn |
Largest origins, 2025: QZ €808 m, QY €480 m.
Latest months, exports to the world: none reported.
Estonia Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €20 | €21,285 |
| 2023 | €7,104 | €12,435 |
| 2024 | €4,213 | €21,384 |
| 2025 | €5,761 | €38,085 |
Largest destinations, 2025: United States €2,511, Türkiye €2,167, Switzerland €1,083.
Largest origins, 2025: China €31,855, Netherlands €3,827, Slovakia €1,064, United States €837, Australia €276, Switzerland €226.
Latest months, exports to the world: 2026-02 €670, 2026-03 €2,767, 2026-04 €1,015, 2026-05 €268, 2026-06 €1,600, 2026-07 €5,117.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €3 m | €12 m |
| 2023 | €4 m | €18 m |
| 2024 | €3 m | €33 m |
| 2025 | €5 m | €44 m |
Largest destinations, 2025: Lithuania €2 m, Russia €845,075, Latvia €663,193, Kazakhstan €522,240, Hungary €187,652, Germany €177,918, Ukraine €169,513, Uzbekistan €167,874, Georgia €115,540, Brazil €71,343.
Largest origins, 2025: Latvia €31 m, Germany €6 m, Lithuania €5 m, Poland €1 m, Hungary €397,332, Italy €333,130, Czechia €287,190, Sweden €249,557, Netherlands €146,408, Slovenia €136,995.
Latest months, exports to the world: 2026-02 €234,651, 2026-03 €1 m, 2026-04 €1 m, 2026-05 €602,785, 2026-06 €481,784, 2026-07 €634,979.
Finland Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €3 | €72,441 |
| 2023 | €334 | €493,162 |
| 2024 | €353 | €390,566 |
| 2025 | €142,172 | €581,754 |
Largest destinations, 2025: Switzerland €125,600, Russia €15,238, United States €1,329, China €2, Israel €2, United Kingdom €1.
Largest origins, 2025: Netherlands €228,523, Russia €143,668, United States €99,220, Austria €59,373, Australia €27,248, Germany €14,362, China €3,915, Canada €2,397, Israel €1,290, Sweden €1,073.
Latest months, exports to the world: 2025-10 €44,602, 2025-11 €81,000, 2025-12 €15,238, 2026-01 €18, 2026-02 €60,170, 2026-03 €3,224.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €18 m | €134 m |
| 2023 | €20 m | €155 m |
| 2024 | €21 m | €151 m |
| 2025 | €22 m | €184 m |
Largest destinations, 2025: Italy €3 m, Brazil €3 m, Poland €3 m, United States €2 m, United Kingdom €2 m, Canada €1 m, Sweden €1 m, Kazakhstan €1 m, Australia €1 m, Japan €899,872.
Largest origins, 2025: Denmark €126 m, Spain €18 m, France €13 m, Germany €9 m, Netherlands €6 m, Belgium €3 m, Sweden €3 m, Switzerland €3 m, Japan €1 m, Poland €1 m.
Latest months, exports to the world: 2026-01 €2 m, 2026-02 €3 m, 2026-03 €2 m, 2026-04 €2 m, 2026-05 €3 m, 2026-06 €3 m.
France Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €22 m | €522 m |
| 2023 | €7 m | €135 m |
| 2024 | €6 m | €670 m |
| 2025 | €15 m | €409 m |
Largest destinations, 2025: Switzerland €6 m, Germany €2 m, Spain €2 m, Czechia €1 m, Iran €908,881, United States €794,553, Israel €732,149, United Kingdom €256,549, China €166,382, India €123,429.
Largest origins, 2025: United States €282 m, Austria €70 m, Switzerland €45 m, Germany €3 m, India €2 m, Uruguay €1 m, China €1 m, Taiwan €1 m, Italy €1 m, Spain €948,405.
Latest months, exports to the world: 2026-01 €238,546, 2026-02 €884,769, 2026-03 €2 m, 2026-04 €143,771, 2026-05 €491,023, 2026-06 €735,323.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €2.9 bn | €1.8 bn |
| 2023 | €3.3 bn | €2.0 bn |
| 2024 | €3.6 bn | €2.3 bn |
| 2025 | €7.8 bn | €7.2 bn |
Largest destinations, 2025: Germany €2.2 bn, United Kingdom €1.3 bn, United States €1.1 bn, Belgium €573 m, Italy €313 m, Spain €260 m, Denmark €221 m, Mexico €179 m, China €162 m, Australia €144 m.
Largest origins, 2025: Italy €4.0 bn, China €1.3 bn, Germany €993 m, Belgium €253 m, United States €217 m, Denmark €137 m, Switzerland €75 m, Spain €66 m, Netherlands €57 m, Austria €29 m.
Latest months, exports to the world: 2026-01 €814 m, 2026-02 €550 m, 2026-03 €455 m, 2026-04 €530 m, 2026-05 €639 m, 2026-06 €675 m.
Germany Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €436 m | €1.3 bn |
| 2023 | €572 m | €2.3 bn |
| 2024 | €758 m | €2.3 bn |
| 2025 | €222 m | €2.6 bn |
Largest destinations, 2025: United States €74 m, Denmark €38 m, Russia €31 m, China €22 m, United Kingdom €11 m, India €10 m, Hungary €8 m, Italy €8 m, Croatia €7 m, France €3 m.
Largest origins, 2025: United States €1.7 bn, Ireland €483 m, Argentina €186 m, Netherlands €61 m, Switzerland €45 m, Sweden €32 m, Israel €31 m, China €21 m, Iceland €9 m, Belgium €6 m.
Latest months, exports to the world: 2026-01 €14 m, 2026-02 €14 m, 2026-03 €20 m, 2026-04 €6 m, 2026-05 €22 m, 2026-06 €12 m.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €4.1 bn | €1.8 bn |
| 2023 | €4.5 bn | €1.8 bn |
| 2024 | €4.5 bn | €2.7 bn |
| 2025 | €6.5 bn | €5.1 bn |
Largest destinations, 2025: United States €1.5 bn, France €572 m, Poland €442 m, Netherlands €296 m, Switzerland €220 m, United Kingdom €180 m, Spain €178 m, China €173 m, Romania €170 m, Italy €165 m.
Largest origins, 2025: France €2.3 bn, Italy €895 m, Denmark €450 m, Switzerland €384 m, Spain €262 m, Ireland €177 m, United Kingdom €125 m, Belgium €106 m, Netherlands €101 m, Czechia €89 m.
Latest months, exports to the world: 2026-01 €787 m, 2026-02 €655 m, 2026-03 €714 m, 2026-04 €614 m, 2026-05 €700 m, 2026-06 €693 m.
Greece Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €966,020 | €769,327 |
| 2023 | €862,826 | €3 m |
| 2024 | €10 m | €6 m |
| 2025 | €4 m | €713,446 |
Largest destinations, 2025: Germany €2 m, United States €992,860, India €667,499, Switzerland €485,002, Sweden €171,740, United Arab Emirates €9,910, Latvia €6,440, Netherlands €5,517, Romania €511, Morocco €5.
Largest origins, 2025: China €447,010, Spain €151,257, Germany €41,538, Netherlands €29,101, Poland €18,550, India €18,295, United States €2,756, France €2,510, United Kingdom €2,144, Ireland €201.
Latest months, exports to the world: 2026-02 €119,418, 2026-03 €924,111, 2026-04 €7,893, 2026-05 €1,147, 2026-06 €27,135, 2026-07 €3,223.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €46 m | €142 m |
| 2023 | €76 m | €135 m |
| 2024 | €134 m | €123 m |
| 2025 | €182 m | €197 m |
Largest destinations, 2025: Ireland €32 m, Malta €20 m, France €18 m, Germany €16 m, Slovenia €13 m, Spain €13 m, Czechia €10 m, Austria €9 m, Switzerland €8 m, Cyprus €7 m.
Largest origins, 2025: Germany €65 m, Spain €42 m, Italy €29 m, France €27 m, Belgium €13 m, Switzerland €11 m, Netherlands €5 m, Austria €1 m, Malta €743,217, Ireland €558,041.
Latest months, exports to the world: 2026-02 €7 m, 2026-03 €6 m, 2026-04 €5 m, 2026-05 €7 m, 2026-06 €7 m, 2026-07 €4 m.
Hungary Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €12,674 | €18 m |
| 2023 | €24,503 | €19 m |
| 2024 | €44,179 | €19 m |
| 2025 | €50,085 | €22 m |
Largest destinations, 2025: United Kingdom €49,102, Brazil €743, XS €238, Uzbekistan €2, Kazakhstan €0.
Largest origins, 2025: Austria €9 m, Germany €9 m, Israel €2 m, China €1 m, Greece €130,325, Latvia €42,058, Poland €25,943, India €18,736, France €3,238, United States €2,412.
Latest months, exports to the world: 2026-02 €305,235, 2026-03 €2 m, 2026-04 €2 m, 2026-05 €0, 2026-06 €2 m, 2026-07 €11.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €279 m | €159 m |
| 2023 | €285 m | €144 m |
| 2024 | €229 m | €162 m |
| 2025 | €223 m | €256 m |
Largest destinations, 2025: United Kingdom €25 m, Spain €20 m, Poland €18 m, Germany €15 m, Czechia €14 m, Russia €13 m, Romania €11 m, Italy €11 m, Denmark €9 m, United States €8 m.
Largest origins, 2025: Germany €85 m, France €58 m, Denmark €33 m, Belgium €30 m, Netherlands €16 m, Romania €10 m, Italy €9 m, Slovakia €5 m, Spain €4 m, Slovenia €2 m.
Latest months, exports to the world: 2026-02 €20 m, 2026-03 €27 m, 2026-04 €26 m, 2026-05 €21 m, 2026-06 €33 m, 2026-07 €20 m.
Ireland Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €6.0 bn | €7 m |
| 2023 | €10.4 bn | €13 m |
| 2024 | €16.7 bn | €17 m |
| 2025 | €53.9 bn | €14 m |
Largest destinations, 2025: United States €50.9 bn, Italy €2.3 bn, Germany €510 m, Belgium €220 m, Switzerland €12 m, QV €239,232, United Kingdom €108,215, France €47,102, Spain €39,896, Denmark €21,455.
Largest origins, 2025: United States €7 m, Italy €3 m, Sweden €3 m, Switzerland €915,020, Netherlands €631,685, China €446,869, Germany €94,021, United Kingdom €89,128, India €19,330, France €13,475.
Latest months, exports to the world: 2026-02 €31 m, 2026-03 €151 m, 2026-04 €117 m, 2026-05 €91 m, 2026-06 €97 m, 2026-07 €153 m.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €426 m | €151 m |
| 2023 | €308 m | €187 m |
| 2024 | €348 m | €243 m |
| 2025 | €778 m | €1.6 bn |
Largest destinations, 2025: United Kingdom €196 m, United States €181 m, Germany €159 m, Switzerland €74 m, Netherlands €34 m, Italy €29 m, France €19 m, Belgium €18 m, Spain €8 m, Mexico €7 m.
Largest origins, 2025: Italy €1.4 bn, Denmark €69 m, Germany €54 m, Belgium €15 m, Netherlands €14 m, France €6 m, United Kingdom €3 m, Switzerland €3 m, Spain €2 m, United States €2 m.
Latest months, exports to the world: 2026-02 €302 m, 2026-03 €351 m, 2026-04 €487 m, 2026-05 €274 m, 2026-06 €484 m, 2026-07 €847 m.
Italy Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €11 m | €2.0 bn |
| 2023 | €8 m | €5.1 bn |
| 2024 | €9 m | €8.8 bn |
| 2025 | €9 m | €21.4 bn |
Largest destinations, 2025: United States €3 m, Iran €3 m, Uruguay €1 m, France €993,286, Switzerland €317,265, India €57,455, South Korea €47,501, China €40,780, Ireland €37,574, Argentina €27,350.
Largest origins, 2025: United States €13.0 bn, China €5.6 bn, Ireland €2.2 bn, Germany €356 m, Switzerland €193 m, France €43 m, Spain €3 m, India €905,327, Austria €516,342, Sweden €118,504.
Latest months, exports to the world: 2026-01 €13 m, 2026-02 €743,644, 2026-03 €339,286, 2026-04 €335,908, 2026-05 €512,945, 2026-06 €3 m.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €4.9 bn | €2.2 bn |
| 2023 | €4.7 bn | €1.5 bn |
| 2024 | €9.2 bn | €1.5 bn |
| 2025 | €20.0 bn | €2.9 bn |
Largest destinations, 2025: United States €5.4 bn, France €4.0 bn, Spain €3.1 bn, Ireland €1.4 bn, United Kingdom €1.0 bn, Belgium €717 m, Germany €712 m, Saudi Arabia €575 m, China €526 m, Australia €462 m.
Largest origins, 2025: China €1.4 bn, Denmark €461 m, France €319 m, Germany €170 m, Belgium €143 m, Switzerland €142 m, United States €101 m, Netherlands €45 m, Hungary €30 m, Spain €29 m.
Latest months, exports to the world: 2026-01 €1.7 bn, 2026-02 €1.5 bn, 2026-03 €1.7 bn, 2026-04 €1.4 bn, 2026-05 €1.5 bn, 2026-06 €1.9 bn.
Latvia Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €924,679 | €23,135 |
| 2023 | €974,661 | €119,209 |
| 2024 | €1 m | €166,638 |
| 2025 | €1 m | €113,374 |
Largest destinations, 2025: Belgium €269,200, Slovakia €201,769, Poland €85,785, Brazil €81,530, Czechia €69,500, United States €48,364, Indonesia €47,150, Hungary €42,000, Netherlands €34,300, Chile €31,141.
Largest origins, 2025: India €102,240, Germany €6,986, China €3,204, France €944.
Latest months, exports to the world: 2026-02 €383,271, 2026-03 €121,193, 2026-04 €113,242, 2026-05 €133,293, 2026-06 €70,032, 2026-07 €154,923.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €47 m | €52 m |
| 2023 | €57 m | €66 m |
| 2024 | €58 m | €65 m |
| 2025 | €80 m | €98 m |
Largest destinations, 2025: Lithuania €42 m, Estonia €31 m, Uzbekistan €2 m, Tunisia €450,326, United Kingdom €410,525, Afghanistan €358,277, Tajikistan €347,599, Kyrgyzstan €255,028, Zambia €247,802, Congo - Kinshasa €239,347.
Largest origins, 2025: Denmark €45 m, France €38 m, Germany €6 m, Lithuania €3 m, Sweden €2 m, Switzerland €699,791, Estonia €696,656, Netherlands €515,155, Poland €379,005, Slovenia €377,644.
Latest months, exports to the world: 2026-02 €8 m, 2026-03 €8 m, 2026-04 €11 m, 2026-05 €7 m, 2026-06 €7 m, 2026-07 €10 m.
Lithuania Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €1,672 | €10,593 |
| 2023 | €52,984 | €655,072 |
| 2024 | €145,798 | €162,440 |
| 2025 | €1 m | €2 m |
Largest destinations, 2025: Netherlands €974,450, Hungary €309,767, Sweden €65,755, Germany €23,290, Portugal €13,616, Poland €8,500, Latvia €695, Czechia €293.
Largest origins, 2025: Slovenia €724,327, Croatia €464,470, China €214,815, Czechia €151,726, United States €73,941, Canada €19,672, France €7,736, Austria €7,328, South Korea €4,981, Ireland €2,492.
Latest months, exports to the world: 2026-02 €155,286, 2026-03 €592,140, 2026-04 €892,458, 2026-05 €573,206, 2026-06 €525,514, 2026-07 €281,039.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €34 m | €50 m |
| 2023 | €33 m | €56 m |
| 2024 | €45 m | €64 m |
| 2025 | €44 m | €78 m |
Largest destinations, 2025: Germany €14 m, Latvia €6 m, Estonia €5 m, Hungary €3 m, Poland €3 m, Netherlands €2 m, Spain €2 m, Czechia €2 m, Belarus €2 m, Italy €1 m.
Largest origins, 2025: Latvia €27 m, Poland €11 m, Germany €10 m, United States €8 m, Belgium €6 m, Hungary €2 m, Czechia €2 m, Austria €2 m, France €2 m, Netherlands €2 m.
Latest months, exports to the world: 2026-02 €3 m, 2026-03 €3 m, 2026-04 €4 m, 2026-05 €3 m, 2026-06 €6 m, 2026-07 €5 m.
Luxembourg Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €1,536 | €5,308 |
| 2023 | €6,830 | €7,227 |
| 2024 | €18,477 | €20,024 |
| 2025 | €3,988 | €7,149 |
Largest destinations, 2025: Germany €3,717, QV €271.
Largest origins, 2025: United States €5,677, Israel €824, Netherlands €648.
Latest months, exports to the world: 2025-10 €540, 2025-11 €465, 2025-12 €893, 2026-03 €930.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €746,271 | €2 m |
| 2023 | €1 m | €2 m |
| 2024 | €2 m | €2 m |
| 2025 | €2 m | €3 m |
Largest destinations, 2025: Belgium €2 m, Netherlands €78,970, Germany €53,420, Spain €15,120, Saudi Arabia €902, Mauritius €438, Armenia €100, United Kingdom €52, Algeria €51, Morocco €30.
Largest origins, 2025: Belgium €2 m, Sweden €549,108, Netherlands €185,619, Denmark €26,180, France €13,479, Germany €6,163, United Kingdom €1,480, India €175, Poland €136, Czechia €31.
Latest months, exports to the world: 2026-01 €339,716, 2026-02 €79,851, 2026-03 €215,413, 2026-04 €308,602, 2026-05 €140,473, 2026-06 €176,163.
Malta Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | not reported | €1,721 |
| 2023 | not reported | €94 |
| 2024 | not reported | €1,825 |
| 2025 | not reported | €4,591 |
Largest origins, 2025: United States €3,424, United Kingdom €662, India €505.
Latest months, exports to the world: none reported.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €3 m | €8 m |
| 2023 | €182,227 | €3 m |
| 2024 | €2 m | €3 m |
| 2025 | €3 m | €6 m |
Largest destinations, 2025: United Kingdom €2 m, France €498,416, Germany €201,777, Netherlands €172,500, Lithuania €153,750, Italy €117,331, Spain €56,242, Libya €31,584, Belgium €25,693, Bulgaria €21,666.
Largest origins, 2025: Spain €2 m, Germany €1 m, Switzerland €444,912, Greece €294,305, Ireland €196,822, Hungary €190,353, United Kingdom €189,115, Netherlands €159,410, Italy €155,022, India €127,568.
Latest months, exports to the world: 2026-01 €150,282, 2026-02 €2 m, 2026-03 €4 m, 2026-04 €887,083, 2026-05 €1 m, 2026-06 €89,419.
Netherlands Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €61 m | €10 m |
| 2023 | €58 m | €4 m |
| 2024 | €82 m | €8 m |
| 2025 | €78 m | €7 m |
Largest destinations, 2025: Germany €60 m, United States €5 m, Japan €5 m, Denmark €2 m, Switzerland €2 m, Italy €803,699, Sweden €596,193, France €573,601, Belgium €472,112, Australia €398,860.
Largest origins, 2025: Italy €2 m, China €1 m, Belgium €1 m, United States €900,384, India €560,013, Germany €290,212, Spain €152,229, Australia €130,197, United Kingdom €44,622, Hong Kong SAR China €35,221.
Latest months, exports to the world: 2026-01 €9 m, 2026-02 €1 m, 2026-03 €10 m, 2026-04 €2 m, 2026-05 €5 m, 2026-06 €9 m.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €2.3 bn | €1.3 bn |
| 2023 | €2.2 bn | €1.0 bn |
| 2024 | €2.2 bn | €1.0 bn |
| 2025 | €2.2 bn | €1.5 bn |
Largest destinations, 2025: Switzerland €1.0 bn, China €294 m, United States €179 m, Germany €83 m, United Kingdom €70 m, France €46 m, Belgium €41 m, Spain €30 m, Australia €27 m, Italy €25 m.
Largest origins, 2025: Switzerland €674 m, United States €204 m, Germany €185 m, Belgium €152 m, France €114 m, Denmark €101 m, Ireland €36 m, Japan €19 m, Spain €7 m, Sweden €7 m.
Latest months, exports to the world: 2026-01 €99 m, 2026-02 €82 m, 2026-03 €102 m, 2026-04 €118 m, 2026-05 €117 m, 2026-06 €143 m.
Poland Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €99,687 | €336,743 |
| 2023 | €48,015 | €216,929 |
| 2024 | €20,630 | €562,320 |
| 2025 | €46,565 | €881,712 |
Largest destinations, 2025: Belarus €28,854, Brazil €5,682, Ukraine €3,846, Switzerland €3,422, United Arab Emirates €2,626, XS €930, Iraq €877, Kazakhstan €328.
Largest origins, 2025: China €764,512, Belgium €83,674, Canada €14,657, India €9,063, Germany €6,863, United States €2,882, Czechia €44, South Africa €17.
Latest months, exports to the world: 2026-01 €2,343, 2026-02 €1,766, 2026-03 €2,388, 2026-04 €2,233, 2026-05 €8,241, 2026-06 €6,519.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €57 m | €315 m |
| 2023 | €87 m | €439 m |
| 2024 | €128 m | €634 m |
| 2025 | €126 m | €918 m |
Largest destinations, 2025: South Korea €17 m, Denmark €17 m, Germany €9 m, Russia €9 m, Romania €7 m, Taiwan €6 m, Czechia €6 m, Italy €6 m, Brazil €6 m, Lithuania €5 m.
Largest origins, 2025: Germany €290 m, Denmark €275 m, France €177 m, Hungary €43 m, Austria €42 m, Belgium €20 m, Netherlands €12 m, Italy €11 m, Czechia €9 m, Switzerland €9 m.
Latest months, exports to the world: 2026-01 €11 m, 2026-02 €14 m, 2026-03 €12 m, 2026-04 €14 m, 2026-05 €14 m, 2026-06 €11 m.
Portugal Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €10 | €109,029 |
| 2023 | not reported | €149,246 |
| 2024 | €696,348 | €74,525 |
| 2025 | €3 | €245,637 |
Largest destinations, 2025: Jordan €3.
Largest origins, 2025: United States €187,063, China €38,808, France €8,443, Germany €4,693, United Kingdom €3,163, Spain €2,555, Israel €385, Oman €307, Ireland €220.
Latest months, exports to the world: 2025-11 €3, 2026-02 €3, 2026-04 €6, 2026-05 €125, 2026-07 €98.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €40 m | €122 m |
| 2023 | €86 m | €143 m |
| 2024 | €83 m | €192 m |
| 2025 | €85 m | €352 m |
Largest destinations, 2025: United States €50 m, Mexico €8 m, Germany €6 m, Switzerland €4 m, Czechia €3 m, France €3 m, Spain €1 m, Canada €905,691, Netherlands €895,536, Iran €877,055.
Largest origins, 2025: Spain €92 m, Denmark €77 m, France €60 m, Italy €49 m, Germany €39 m, Hungary €17 m, Belgium €5 m, Netherlands €5 m, Switzerland €3 m, Ireland €2 m.
Latest months, exports to the world: 2026-02 €5 m, 2026-03 €4 m, 2026-04 €9 m, 2026-05 €7 m, 2026-06 €9 m, 2026-07 €5 m.
Romania Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €91,577 | €196,040 |
| 2023 | €221,832 | €386,619 |
| 2024 | €355,462 | €240,965 |
| 2025 | €94,179 | €161,828 |
Largest destinations, 2025: Bulgaria €54,841, Germany €21,315, Hungary €10,939, Italy €4,726, Latvia €645, Ireland €563, Netherlands €499, Lithuania €363, Czechia €288.
Largest origins, 2025: India €78,822, China €39,378, Germany €35,189, Latvia €6,051, Ireland €772, Austria €560, Estonia €483, Slovakia €385, France €188.
Latest months, exports to the world: 2025-11 €375, 2025-12 €613, 2026-01 €2,942, 2026-02 €4,277, 2026-04 €1,540, 2026-05 €5,737.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €28 m | €163 m |
| 2023 | €35 m | €236 m |
| 2024 | €51 m | €238 m |
| 2025 | €69 m | €415 m |
Largest destinations, 2025: Hungary €15 m, Netherlands €12 m, Germany €10 m, Czechia €9 m, Ireland €5 m, Denmark €5 m, Lithuania €4 m, Spain €2 m, Bulgaria €2 m, France €1 m.
Largest origins, 2025: Denmark €198 m, Germany €150 m, Hungary €12 m, Bulgaria €10 m, France €10 m, Slovakia €7 m, Belgium €6 m, Netherlands €4 m, Slovenia €3 m, Austria €3 m.
Latest months, exports to the world: 2026-01 €3 m, 2026-02 €9 m, 2026-03 €9 m, 2026-04 €6 m, 2026-05 €7 m, 2026-06 €7 m.
Slovakia Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €1,736 | €123,483 |
| 2023 | €8,957 | €60,585 |
| 2024 | €55,215 | €178,531 |
| 2025 | €123,218 | €456,731 |
Largest destinations, 2025: Latvia €75,666, Denmark €19,153, Germany €9,425, Italy €4,721, United States €3,456, Spain €2,323, Netherlands €1,947, Estonia €1,064, United Kingdom €930, France €922.
Largest origins, 2025: Latvia €210,573, China €206,612, United States €20,932, Czechia €6,050, Denmark €2,867, Germany €2,467, France €1,854, Canada €1,067, Japan €1,040, Uruguay €963.
Latest months, exports to the world: 2026-01 €7,776, 2026-02 €3,282, 2026-03 €3,068, 2026-04 €4,248, 2026-05 €3,056, 2026-06 €2,596.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €35 m | €70 m |
| 2023 | €35 m | €82 m |
| 2024 | €35 m | €104 m |
| 2025 | €42 m | €123 m |
Largest destinations, 2025: Czechia €22 m, Romania €7 m, Hungary €6 m, Latvia €4 m, Germany €1 m, Lithuania €532,320, Poland €520,914, United Kingdom €412,946, Netherlands €217,703, Croatia €90,707.
Largest origins, 2025: Denmark €46 m, Czechia €23 m, Italy €17 m, Germany €10 m, Romania €8 m, Netherlands €5 m, Belgium €5 m, Switzerland €3 m, France €2 m, Hungary €1 m.
Latest months, exports to the world: 2026-01 €6 m, 2026-02 €6 m, 2026-03 €4 m, 2026-04 €4 m, 2026-05 €5 m, 2026-06 €5 m.
Slovenia Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €21,621 | €236,428 |
| 2023 | €24,490 | €509,613 |
| 2024 | €194,563 | €1 m |
| 2025 | €16,214 | €2 m |
Largest destinations, 2025: United Kingdom €10,582, India €4,604, Bosnia & Herzegovina €773, Germany €251, Russia €2, Mexico €1, Malaysia €1.
Largest origins, 2025: Switzerland €1 m, China €218,242, Netherlands €147,890, Germany €16,661, Israel €14,114, France €13,362, Australia €11,232, India €3,579, United States €380, Croatia €301.
Latest months, exports to the world: 2025-10 €251, 2025-12 €2,264, 2026-01 €5, 2026-02 €46,076, 2026-03 €2,898, 2026-04 €5.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €60 m | €65 m |
| 2023 | €83 m | €77 m |
| 2024 | €110 m | €103 m |
| 2025 | €108 m | €108 m |
Largest destinations, 2025: Kazakhstan €15 m, Denmark €14 m, XS €9 m, Croatia €9 m, Kuwait €5 m, Russia €4 m, France €4 m, Bosnia & Herzegovina €4 m, Switzerland €4 m, Romania €3 m.
Largest origins, 2025: Austria €21 m, Denmark €14 m, Germany €14 m, France €11 m, United States €10 m, Cyprus €8 m, Belgium €7 m, Italy €7 m, Netherlands €3 m, Ireland €3 m.
Latest months, exports to the world: 2026-01 €6 m, 2026-02 €7 m, 2026-03 €6 m, 2026-04 €11 m, 2026-05 €8 m, 2026-06 €8 m.
Spain Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €43 m | €93 m |
| 2023 | €48 m | €86 m |
| 2024 | €51 m | €103 m |
| 2025 | €61 m | €111 m |
Largest destinations, 2025: Italy €25 m, Switzerland €20 m, India €4 m, United States €2 m, Mexico €2 m, Germany €2 m, France €1 m, Austria €926,575, Australia €885,050, Netherlands €429,088.
Largest origins, 2025: United States €100 m, France €3 m, Netherlands €2 m, Germany €2 m, China €2 m, Argentina €2 m, Sweden €835,422, Austria €293,983, India €177,236, Switzerland €81,711.
Latest months, exports to the world: 2026-02 €5 m, 2026-03 €3 m, 2026-04 €5 m, 2026-05 €6 m, 2026-06 €6 m, 2026-07 €6 m.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €318 m | €546 m |
| 2023 | €388 m | €645 m |
| 2024 | €666 m | €1.3 bn |
| 2025 | €2.9 bn | €3.8 bn |
Largest destinations, 2025: United Kingdom €1.7 bn, Germany €269 m, Australia €151 m, United States €141 m, Türkiye €96 m, Portugal €80 m, Sweden €73 m, Belgium €69 m, Denmark €59 m, Greece €43 m.
Largest origins, 2025: Italy €2.9 bn, Germany €393 m, France €238 m, United States €86 m, Belgium €82 m, Netherlands €36 m, Hungary €22 m, Switzerland €17 m, Slovenia €11 m, Greece €7 m.
Latest months, exports to the world: 2026-02 €195 m, 2026-03 €203 m, 2026-04 €222 m, 2026-05 €156 m, 2026-06 €205 m, 2026-07 €201 m.
Sweden Eurostat Comext, EUR
CN 29371900: polypeptide, protein and glycoprotein hormones other than somatropin and insulin (bulk substance)
| Year | Exports | Imports |
|---|---|---|
| 2022 | €88 m | €5 m |
| 2023 | €118 m | €3 m |
| 2024 | €103 m | €4 m |
| 2025 | €115 m | €5 m |
Largest destinations, 2025: United States €51 m, Germany €50 m, Ireland €5 m, Singapore €4 m, United Kingdom €1 m, Spain €896,244, South Korea €881,914, Austria €608,569, Czechia €511,424, Japan €372,520.
Largest origins, 2025: United States €3 m, Germany €1 m, Netherlands €552,471, China €240,045, Greece €175,608, India €52,704, Japan €32,803, France €24,040, Canada €23,967, United Kingdom €14,087.
Latest months, exports to the world: 2026-01 €10 m, 2026-02 €6 m, 2026-03 €12 m, 2026-04 €15 m, 2026-05 €14 m, 2026-06 €12 m.
CN 30043900: medicines in measured doses containing such hormones, other than insulin and corticosteroids
| Year | Exports | Imports |
|---|---|---|
| 2022 | €103 m | €180 m |
| 2023 | €107 m | €204 m |
| 2024 | €129 m | €272 m |
| 2025 | €150 m | €282 m |
Largest destinations, 2025: United States €42 m, Belgium €38 m, Denmark €16 m, United Kingdom €16 m, Norway €12 m, Netherlands €9 m, Germany €4 m, France €4 m, Finland €3 m, Lithuania €2 m.
Largest origins, 2025: Denmark €106 m, Spain €58 m, Italy €26 m, Netherlands €26 m, Germany €22 m, Belgium €16 m, France €10 m, Finland €5 m, Switzerland €5 m, Hungary €3 m.
Latest months, exports to the world: 2026-01 €7 m, 2026-02 €4 m, 2026-03 €3 m, 2026-04 €14 m, 2026-05 €7 m, 2026-06 €29 m.
Who makes and holds each peptide is on its Companies tab, from registers that name the company: all companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.